Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Fluorouracil 500 / Epirubicin 90 / Cyclophosphamide 600 / Trastuzumab 8 / Pertuzumab 840, Breast Cancer, neoadjuvant, cycle 1

Protocol-ID: 1467 V1.0 (Mini), FEC (FU500/EPIR90/CYCL600)/TRAS8/PERT840, Breast Ca, neoadj., C1

Indication(s)

  • Breast Cancer (HER2+); ICD-10 C50.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 28.03.2020